Literature DB >> 30707963

First birth of a healthy infant following intra-cytoplasmic sperm injection using a new permeable cryoprotectant-free sperm vitrification protocol.

Llanos Medrano1, María Enciso2, María José Gomez-Torres3, Jon Aizpurua4.   

Abstract

PURPOSE: The purpose of this study is to present the first birth of healthy infant born following ICSI using the new permeable cryoprotectant-free sperm vitrification protocol Easy-Sperm®. PRINCIPAL
RESULTS: A 39 years old woman and his 40 years old partner underwent egg donation treatment at IVF-Spain Alicante (Spain). Half of the mature oocytes obtained from a young and healthy donor were fertilized by ICSI, using slow-frozen spermatozoa and the other half with vitrified spermatozoa. A total of 5 blastocysts were obtained on day 5 (3 resulting from vitrified spermatozoa and 2 from frozen sperm). The best embryo, with AA quality (derived from one of the oocytes fertilized with vitrified sperm) was transferred. The woman conceived and, following a normal pregnancy, delivered a healthy boy.
CONCLUSIONS: To the best of our knowledge, this is the first case report of a successful pregnancy and delivery of a healthy infant from ICSI with permeable vitrified spermatozoa in an oocyte donation program with transfer on blastocyst stage.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blastocyst; Live birth; Oocyte donation; Sperm cryopreservation; Sperm vitrification

Mesh:

Substances:

Year:  2019        PMID: 30707963     DOI: 10.1016/j.cryobiol.2019.01.014

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  2 in total

1.  Ultra-Rapid Freezing Preserves Morphofunctional Integrity and Fertilizing Ability of Epididymal Cat Spermatozoa.

Authors:  Martina Colombo; Maria Giorgia Morselli; Jennifer Zahmel; Gaia Cecilia Luvoni
Journal:  Front Vet Sci       Date:  2022-06-14

Review 2.  Human sperm vitrification: the state of the art.

Authors:  Yong Tao; Erika Sanger; Arpornrad Saewu; Marie-Claude Leveille
Journal:  Reprod Biol Endocrinol       Date:  2020-03-07       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.